Becton, Dickinson and Co. | BDX - Current Assets

Stock Price
185.39
Daily Change
2.92 1.60%
Monthly
-10.08%
Yearly
-18.48%
Q1 Forecast
179.64

Becton, Dickinson and Co. reported $9.19B in Current Assets for its fiscal quarter ending in December of 2025.





Current Assets Change Date
Abbott USD 26B 1.16B Dec/2025
Agilent USD 4.59B 341M Sep/2025
Align Technology USD 2.62B 82.47M Dec/2025
AngioDynamics USD 172.27M 3.09M Feb/2025
Avanos Medical USD 351.4M 4.6M Sep/2025
Baxter International USD 6.87B 61M Dec/2025
Becton, Dickinson and Co. USD 9.19B 66M Dec/2025
Bio-Rad Laboratories USD 2.91B 64.2M Dec/2025
Boston Scientific USD 8.79B 759M Dec/2025
Cooper Companies USD 2.11B 31.4M Sep/2025
Danaher USD 12.76B 3.15B Dec/2025
Dentsply International USD 2.07B 106M Sep/2025
Dexcom USD 4.03B 1.19B Dec/2025
Edwards Lifesciences USD 6.36B 218.3M Sep/2025
Exact Sciences USD 1.56B 34.88M Dec/2025
Globus Medical USD 1.92B 194.46M Sep/2025
Hologic USD 3.84B 175.3M Dec/2025
Insulet USD 1.91B 54.6M Dec/2025
Integra LifeSciences USD 1.14B 754K Sep/2025
Intuitive Surgical USD 12.4B 927.3M Dec/2025
J&J USD 55.62B 1.01B Dec/2025
Masimo USD 1.05B 221.5M Sep/2025
Medtronic USD 24B 773M Sep/2025
Solventum Corp USD 4.41B 1.2B Sep/2025
Stryker USD 14.76B 1.04B Dec/2025
Tandem Diabetes Care USD 618.14M 1.2M Dec/2025
Teleflex USD 1.99B 262.12M Sep/2025
Terumo JPY 815.56B 71.48B Dec/2025
Thermo Fisher Scientific USD 28.71B 6.41B Dec/2025
Zimmer Biomet Holdings USD 5.12B 715M Dec/2025